$DFTX
Price history, market instrument context, member research, and related headlines in one place.
DFTX key statistics
NasdaqGSUSD
52-week range
$10.4761%$49.70
Latest session $33.93–$34.79Definium Therapeutics, Inc. (DFTX) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $34.26, up $0.02 (0.06%) from the previous close of $34.24. It has traded between $33.93 and $34.79 in the latest session. Over the past year it has ranged from $10.47 to $49.70, leaving it in the upper half of its 52-week range (61%). Reported volume for the session was 1.7M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
BofA initiates Definium Therapeutics stock with buy on psychedelic drug potential — See source for full details.
Definium outlines cash runway into 2030 as Voyage GAD Phase III top line results near — See source for full details.
Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Small Cap Growth Fund”. A copy of the letter can be downloaded here. The U.S. market saw a strong rally in the second quarter, fueled by easing geopolitical tensions, falling oil prices, and robust corporate earnings. Growth stocks, especially in technology and […]
Loading $DFTX research…